Inga Grünewald

1.3k total citations
36 papers, 936 citations indexed

About

Inga Grünewald is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Inga Grünewald has authored 36 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 10 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Inga Grünewald's work include Salivary Gland Tumors Diagnosis and Treatment (7 papers), Sarcoma Diagnosis and Treatment (6 papers) and Ear and Head Tumors (3 papers). Inga Grünewald is often cited by papers focused on Salivary Gland Tumors Diagnosis and Treatment (7 papers), Sarcoma Diagnosis and Treatment (6 papers) and Ear and Head Tumors (3 papers). Inga Grünewald collaborates with scholars based in Germany, Sweden and United States. Inga Grünewald's co-authors include Eva Wardelmann, Wolfgang Hartmann, Reinhard Büttner, Marcel Trautmann, Sebastian Huss, Max Schlaak, Nicole Kreuzberg, Hans‐Ulrich Schildhaus, Katharina König and Jana Fassunke and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Inga Grünewald

32 papers receiving 925 citations

Peers

Inga Grünewald
Keigo Yorozu United States
Diana L. Hanna United States
Marilyn M. Giacomini United States
Inga Grünewald
Citations per year, relative to Inga Grünewald Inga Grünewald (= 1×) peers Robert Cummins

Countries citing papers authored by Inga Grünewald

Since Specialization
Citations

This map shows the geographic impact of Inga Grünewald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inga Grünewald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inga Grünewald more than expected).

Fields of papers citing papers by Inga Grünewald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inga Grünewald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inga Grünewald. The network helps show where Inga Grünewald may publish in the future.

Co-authorship network of co-authors of Inga Grünewald

This figure shows the co-authorship network connecting the top 25 collaborators of Inga Grünewald. A scholar is included among the top collaborators of Inga Grünewald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inga Grünewald. Inga Grünewald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bommer, Martin, Gert Gabriëls, Hermann Pavenstädt, et al.. (2023). Liver Injury after Selective Androgen Receptor Modulator Intake: A Case Report and Review of the Literature. Zeitschrift für Gastroenterologie. 62(6). 935–943. 2 indexed citations
2.
Erkut, Cihan, Inga Grünewald, Eva Wardelmann, et al.. (2022). Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma. Oncogenesis. 11(1). 20–20. 20 indexed citations
3.
Grünewald, Inga, Olle Larsson, Christoph Schliemann, et al.. (2022). SS18-SSX drives CREB activation in synovial sarcoma. Cellular Oncology. 45(3). 399–413. 9 indexed citations
4.
Baumhoer, Daniel, Baptiste Ameline, Inga Grünewald, et al.. (2021). Recurrent CTNNB1 mutations in craniofacial osteomas. Modern Pathology. 35(4). 489–494. 9 indexed citations
5.
Trautmann, Marcel, Heidrun Gevensleben, Jessica Becker, et al.. (2020). Novel pathogenic alterations in pediatric and adult desmoid-type fibromatosis – A systematic analysis of 204 cases. Scientific Reports. 10(1). 3368–3368. 28 indexed citations
6.
Grünewald, Inga, et al.. (2020). ATP7B knockout disturbs copper and lipid metabolism in Caco-2 cells. PLoS ONE. 15(3). e0230025–e0230025. 11 indexed citations
7.
Trautmann, Marcel, Arne Krüger, Inga Grünewald, et al.. (2019). Phosphatidylinositol-3-kinase (PI3K)/Akt Signaling is Functionally Essential in Myxoid Liposarcoma. Molecular Cancer Therapeutics. 18(4). 834–844. 28 indexed citations
8.
Kailayangiri, Sareetha, Bianca Altvater, Claudia Rössig, et al.. (2019). SS18-SSX–Dependent YAP/TAZ Signaling in Synovial Sarcoma. Clinical Cancer Research. 25(12). 3718–3731. 38 indexed citations
9.
Renner, Marcus, Gunhild Mechtersheimer, Pierre Åman, et al.. (2019). Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone. Scientific Reports. 9(1). 19704–19704. 23 indexed citations
10.
Angenendt, Linus, Jan‐Henrik Mikesch, Dennis Görlich, et al.. (2018). Stromal collagen type VI associates with features of malignancy and predicts poor prognosis in salivary gland cancer. Cellular Oncology. 41(5). 517–525. 8 indexed citations
11.
Mikesch, Jan‐Henrik, Wolfgang Hartmann, Linus Angenendt, et al.. (2018). AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short report. Cellular Oncology. 41(4). 455–462. 7 indexed citations
12.
Trautmann, Marcel, Konrad Steinestel, Inga Grünewald, et al.. (2017). FUS–DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma. Clinical Cancer Research. 23(20). 6227–6238. 38 indexed citations
13.
Zibert, Andree, Hans Zischka, Michael Sperling, et al.. (2017). Spatial investigation of the elemental distribution in Wilson’s disease liver after d -penicillamine treatment by LA-ICP-MS. Journal of Trace Elements in Medicine and Biology. 44. 26–31. 17 indexed citations
14.
Wardelmann, Eva, et al.. (2016). Prognostic relevance of epithelial–mesenchymal transition and proliferation in surgically treated primary parotid gland cancer. Journal of Clinical Pathology. 70(5). 403–409. 8 indexed citations
15.
Schmidt, L. H., Andreas Kümmel, Dennis Görlich, et al.. (2015). PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups. PLoS ONE. 10(8). e0136023–e0136023. 197 indexed citations
16.
Grünewald, Inga, Claudia Vollbrecht, Moritz Meyer, et al.. (2015). Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity. Oncotarget. 6(20). 18224–18237. 69 indexed citations
17.
Steinestel, Konrad, Eva Wardelmann, Wolfgang Hartmann, & Inga Grünewald. (2015). Regulators of Actin Dynamics in Gastrointestinal Tract Tumors. Gastroenterology Research and Practice. 2015. 1–11. 6 indexed citations
19.
Wenzel, Katrin, et al.. (2003). Identification and Characterization of KAT, a Novel Gene Preferentially Expressed in Several Human Cancer Cell Lines. Biological Chemistry. 384(5). 763–75. 13 indexed citations
20.
Meyer, Silke, Bernd Romeike, Martin Strowitzkí, et al.. (2002). Meningeoangiomatose mit assoziiertem Meningeom bei 4-jährigem Mädchen mit fokalem Krampfanfall. Der Nervenarzt. 73(10). 990–994. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026